Dean Erasmus School of Health Policy & Management Erasmus School of Health Policy & Management
- Location
- Burg. Oudlaan 50, Rotterdam
- Room
- J7-19
- ijzerman@eshpm.eur.nl
Full professor Erasmus School of Health Policy & Management Health Services Management & Organisation (HSMO)
- Location
- Burg. Oudlaan 50, Rotterdam
- Room
- J7-19
- ijzerman@eshpm.eur.nl
‹ Back to overview
Profile
Professor Maarten IJzerman is dean of the Erasmus School of Health Policy and Management and a full professor of Cancer Health Services Research at Erasmus University. He is also affiliated with the University of Melbourne Centre for Cancer Research and the Melbourne School of Population and Global Health. Maarten’s international work is focussed around the health economics and health care delivery of personalised medicine, including research on drug treatment sequencing and the use of complex genomic sequencing.
He is a member of numerous (inter-) national advisory boards related to health services research, clinical governance and cancer management and innovation.
- William V Padula, Noemi Kreif, David J Vanness, Blythe Adamson, Juan-David Rueda, Federico Felizzi, Pall Jonsson, Maarten J IJzerman, Atul Butte & William Crown (2022) - Machine Learning Methods in Health Economics and Outcomes Research-The PALISADE Checklist: A Good Practices Report of an ISPOR Task Force - Value in Health, 25 (7), 1063-1080 - doi: 10.1016/j.jval.2022.03.022 - [link]
- Victoria Freeman, Suzanne Hughes, Chelsea Carle, Denise Campbell, Sam Egger, Harriet Hui, Sarsha Yap, Silvia Deandrea, Michael Caruana, Tonia C Onyeka, Maarten J IJzerman, Ophira Ginsburg, Freddie Bray, Richard Sullivan, Ajay Aggarwal, Stuart J Peacock, Kelvin K W Chan, Timothy P Hanna, Isabelle Soerjomataram, Dianne L O'Connell, Julia Steinberg & Karen Canfell (2022) - Are patients with cancer at higher risk of COVID-19-related death?: A systematic review and critical appraisal of the early evidence - Journal of Cancer Policy, 33, 100340 - doi: 10.1016/j.jcpo.2022.100340 - [link]
- Sophie O’Haire, Koen Degeling, Fanny Franchini, Ben Tran, Stephen J. Luen, Clara Gaff, Kortnye Smith, Stephen Fox, Jayesh Desai & Maarten IJzerman (2022) - Comparing Survival Outcomes for Advanced Cancer Patients Who Received Complex Genomic Profiling Using a Synthetic Control Arm - Targeted Oncology, 17 (5), 539-548 - doi: 10.1007/s11523-022-00910-0 - [link]
- Martin Vu, Koen Degeling, Ella R. Thompson, Piers Blombery, David Westerman & Maarten J. IJzerman (2022) - Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic review - European Journal of Haematology, 108 (6), 469-485 - doi: 10.1111/ejh.13755 - [link]
- Koen Degeling, Maarten J. IJzerman, Catharina G.M. Groothuis-Oudshoorn, Mira D. Franken, Miriam Koopman, Mark S. Clements & Hendrik Koffijberg (2022) - Comparing Modeling Approaches for Discrete Event Simulations With Competing Risks Based on Censored Individual Patient Data: A Simulation Study and Illustration in Colorectal Cancer - Value in Health, 25 (1), 104-115 - doi: 10.1016/j.jval.2021.07.016 - [link]
- Joost J. Enzing, Saskia Knies, Jop Engel, Maarten J. IJzerman, Beate Sander, Rick Vreman, Bert Boer & Werner B.F. Brouwer (2022) - Do Health Technology Assessment organisations consider manufacturers’ costs in relation to drug price?: A study of reimbursement reports - Cost Effectiveness and Resource Allocation, 20 (1) - doi: 10.1186/s12962-022-00383-y - [link]
- Sarah Glewis, Marliese Alexander, Senthil Lingaratnam, Benjamin Lee, Ian Campbell, Mei Krishnasamy, Maarten IJzerman, Mussab Fagery, Sam Harris, Chloe Georgiou, Craig Underhill, Mark Warren, Robert Campbell, Jennifer Martin, Jeanne Tie & Michael Michael (2022) - Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial - Acta Oncologica, 61 (9), 1-4 - doi: 10.1080/0284186x.2022.2109423 - [link]
- Luiza R. Grazziotin, Gillian Currie, Marinka Twilt, Maarten J. Ijzerman, Michelle M.A. Kip, Hendrik Koffijberg, Susanne M. Benseler, Joost F. Swart, Sebastiaan J. Vastert, Nico M. Wulffraat, Rae S.M. Yeung & Deborah A. Marshall (2022) - Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational study - Pediatric Rheumatology, 20 (1) - doi: 10.1186/s12969-022-00682-x - [link]
University of Melbourne
- Startdatum goedkeuring
- september 2022
- Einddatum goedkeuring
- april 2023
- Plaats
- MELBOURNE
- Beschrijving
- Begeleiding promovendi en afronding projecten
Universiteit Twente
- Startdatum goedkeuring
- september 2022
- Einddatum goedkeuring
- december 2023
- Plaats
- ENSCHEDE
- Beschrijving
- Gastregistratie promotor voor laatste 2 promovendi
Laboratorium Microbiologie
- Startdatum goedkeuring
- januari 2023
- Einddatum goedkeuring
- november 2025
- Plaats
- HENGELO
- Beschrijving
- Lid Raad van Toezicht
Thesis HCM
- Niveau
- master
- Year Level
- master
- Jaar
- 2022
- Course Code
- GW4030MV
